ZEN and the art of breast health maintenance
Authors:
- 6 December 2011
- journal article
- review article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 66 (1) , 28-36
Abstract
Zearalenone (ZEN) is a non‐steroidal mycoestrogen that widely contaminates agricultural products. ZEN and its derivatives share similar molecular mechanisms and activity with estrogens and interact with ERα and ERβ leading to changes in the reproductive system in both animals and humans. The reduced form of ZEN, α‐ZEA ralenol, has been used as an anabolic agent for animals and also proposed as hormonal replacement therapy in postmenopausal women. Furthermore, both zearelanol ZEN and derivatives have been patented as oral contraceptives. ZEN has been widely used in the United States since 1969 to improve fattening rates in cattle by increasing growth rate and feed conversion efficiency. Evidence of human harm from this practice is provided by observations of central precocious puberty. As a result, this practice has been banned by the European Union. As ZEN has been associated with breast enlargement in humans, it has been included in many bust‐enhancing dietary supplements but epidemiological evidence is lacking with regard to breast cancer risk. Extensive work with human breast cancer cell lines has shown estrogenic stimulation in those possessing ER but a reduction in DMBA‐induced breast cancers in rodents given ZEN. Protein disulfide isomerase provides a molecular biomarker of dietary exposure to ZEN and its derivatives allowing the detection and control of harmful food intake. The interaction of ZEN with anti‐estrogens, anticancer agents and antioxidants requires further investigation.Keywords
This publication has 77 references indexed in Scilit:
- Expression profiling of the genes responding to zearalenone and its analogues using estrogen‐responsive genesFEBS Letters, 2009
- Effects of zearalenone andα-Zearalenol in comparison with Raloxifene on T47D cellsToxicology Mechanisms and Methods, 2009
- High Growth Rate of Girls with Precocious Puberty Exposed to Estrogenic MycotoxinsThe Journal of Pediatrics, 2008
- High incidence of central precocious puberty in a bounded geographic area of northwest Tuscany: An estrogen disrupter epidemic?Gynecological Endocrinology, 2005
- Antioxidant compounds from four Opuntia cactus pear fruit varietiesFood Chemistry, 2004
- Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer CellsJournal of Biological Chemistry, 2002
- Breast cancer: evidence for xenoestrogen involvement in altering its incidence and risk1998
- Dietary estrogens stimulate human breast cells to enter the cell cycle.Environmental Health Perspectives, 1997
- An epidemic of precocious development in Puerto Rican childrenThe Journal of Pediatrics, 1985
- Environmental Hormone Contamination in Puerto RicoNew England Journal of Medicine, 1984